Yeast extract
CAS 8013-01-2
Yeast extract (CAS 8013-01-2) is a pharmaceutical compound with 0 bioactivity targets and 1,134 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Yeast extract is linked to DTXSID4051247 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| YEAST EXTRACT | 259522 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Yeast extract used for in pharmaceutical contexts?
Yeast extract (CAS 8013-01-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Yeast extract?
Yeast extract has 1,134 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal pain, Abdominal pain upper, Accidental overdose, Adjustment disorder with depressed mood. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Yeast extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Pitera (Saccharomyces/Rice Ferment Filtrate) with EU status "permitted".
What clinical phase is Yeast extract in?
No phase 1-4 clinical development badge is rendered for Yeast extract because the matched compound identifier rows do not contain a max-phase value.